Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - aluminium hydroxide; quil-a; recombinant gp70 sub-type a - misc. vaccines or anti sera - aluminium hydroxide mineral-aluminium-base active 3.0 mg/do; quil-a plant active 10.0 ug/do; recombinant gp70 sub-type a vaccine-antigen/antibody active 102.0 ug/do - immunotherapy - cat | cat - queen | cat - tom | kitten - feline leukaemia virus | disease caused by

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - amphotericin b; neomycin; polymixin b; feline leukaemia virus - inactivated; thiomersal - misc. vaccines or anti sera - amphotericin b antibiotic active 0.0 undefined; neomycin antibiotic active 0.0 undefined; polymixin b antibiotic active 0.0 undefined; feline leukaemia virus - inactivated vaccine-viral active 0.0 undefined; thiomersal mercury other 0.0 undefined - immunotherapy - cat | cat - queen | cat - tom | kitten - feline leukaemia virus | disease caused by

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - quil; aluminium hydroxide; recombinant gp70 sub-type a - parenteral liquid/solution/suspension - quil ungrouped active 10.0 ug/do; aluminium hydroxide mineral-aluminium-base active 3.0 mg/do; recombinant gp70 sub-type a vaccine-antigen/antibody active 102.0 ug/do - immunotherapy - cat | cat - queen | cat - tom | kitten - feline leukaemia virus | vaccine | disease caused by | equine rotavirus

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; croscarmellose sodium - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: magnesium stearate; croscarmellose sodium; colloidal anhydrous silica; microcrystalline cellulose - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); perindopril arginine, quantity: 10 mg - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg; perindopril arginine, quantity: 10 mg - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

United States - English - NLM (National Library of Medicine)

natural health supply - kalmia latifolia leaf (unii: 79n6542n18) (kalmia latifolia leaf - unii:79n6542n18) - indications: to be used for acute self-limiting conditions according to standard homeopathic indications purpose: sun headache rheumatism

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - magnesium sulfate heptahydrate, quantity: 493 mg/ml - injection, concentrated - excipient ingredients: water for injections - indication as at 8 january 2004: parenteral administration of magnesium is indicated in the treatment of acute hypomagnesaemia. magnesium salts are also indicated to prevent hypomagnesaemia in patients receiving total parenteral nutrition. magnesium sulfate is also indicated in the prevention and treatment of life threatening seizures in the treatment of toxemias of pregnancy (pre-eclampsia and eclampsia).

Ireland - English - HPRA (Health Products Regulatory Authority)

imbat limited - propranolol hydrochloride - prolonged release capsules - 80 milligram